Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Amiloride hydrochloride 5mg/5mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amilozide 5mg/50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amilozide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amilofruse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Co-amilofruse tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride + hydrochlorothiazide 5mg/50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Timolol maleate+co-amilozide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amiloride hydrochloride and hydrochlorothiazide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride dihydrate |
Is a |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride+bumetanide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amiloride and atenolol and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amiloride and furosemide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride 5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amiloride hydrochloride + hydrochlorothiazide 5mg/50mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride + hydrochlorothiazide 5mg/50mg tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride dihydrate |
Is modification of (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amiloride hydrochloride + hydrochlorothiazide 5mg/50mg tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 5 mg oral tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has precise active ingredient |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 2.5 mg and hydrochlorothiazide 25 mg oral tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Atenolol+co-amilozide 50mg/2.5mg/25mg capsule (substance) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Amiloride hydrochloride 5 mg and bumetanide 1 mg oral tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Amiloride hydrochloride 5 mg and furosemide 40 mg oral tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride 2.5 mg and cyclopenthiazide 250 microgram oral tablet |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and furosemide 20 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 10 milligram and furosemide 80 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amiloride hydrochloride 2.5 milligram and hydrochlorothiazide 25 milligram and timolol maleate 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amiloride hydrochloride anhydrous (substance) |
Is modification of (attribute) |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely amiloride hydrochloride anhydrous (as amiloride hydrochloride) 5 milligram and furosemide 40 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Amiloride hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |